EE335 Burden of Disease in Patients Who Are Eligible for Bcma-Targeted Immunotherapy for Multiple Myeloma: A Retrospective Claims Database Analysis
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.634
https://www.valueinhealthjournal.com/article/S1098-3015(24)00749-6/fulltext
Section Title :
Section Order :
10108
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00749-6&doi=10.1016/j.jval.2024.03.634